Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model.

Ramsey HE, Oganesian A, Gorska AE, Fuller L, Arrate M, Boyd K, Keer H, Azab M, Savona MR.

Target Oncol. 2020 Mar 28. doi: 10.1007/s11523-020-00709-x. [Epub ahead of print]

PMID:
32222953
2.

Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies.

Fischer MA, Friedlander SY, Arrate MP, Chang H, Gorska AE, Fuller LD, Ramsey HE, Kashyap T, Argueta C, Debler S, Byrne M, Villaume MT, Shaver AC, Senapedis W, Landesman Y, Baloglu E, Shacham S, Savona MR.

Blood Adv. 2020 Feb 11;4(3):586-598. doi: 10.1182/bloodadvances.2019000359.

3.

Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.

Pei S, Pollyea DA, Gustafson A, Stevens BM, Minhajuddin M, Fu R, Riemondy KA, Gillen AE, Sheridan RM, Kim J, Costello JC, Amaya ML, Inguva A, Winters A, Ye H, Krug A, Jones CL, Adane B, Khan N, Ponder J, Schowinsky J, Abbott D, Hammes A, Myers JR, Ashton JM, Nemkov T, D'Alessandro A, Gutman JA, Ramsey HE, Savona MR, Smith CA, Jordan CT.

Cancer Discov. 2020 Jan 23. doi: 10.1158/2159-8290.CD-19-0710. [Epub ahead of print]

PMID:
31974170
4.

Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer.

Lee T, Christov PP, Shaw S, Tarr JC, Zhao B, Veerasamy N, Jeon KO, Mills JJ, Bian Z, Sensintaffar JL, Arnold AL, Fogarty SA, Perry E, Ramsey HE, Cook RS, Hollingshead M, Davis Millin M, Lee KM, Koss B, Budhraja A, Opferman JT, Kim K, Arteaga CL, Moore WJ, Olejniczak ET, Savona MR, Fesik SW.

J Med Chem. 2019 Apr 25;62(8):3971-3988. doi: 10.1021/acs.jmedchem.8b01991. Epub 2019 Apr 16.

PMID:
30929420
5.

A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.

Ramsey HE, Fischer MA, Lee T, Gorska AE, Arrate MP, Fuller L, Boyd KL, Strickland SA, Sensintaffar J, Hogdal LJ, Ayers GD, Olejniczak ET, Fesik SW, Savona MR.

Cancer Discov. 2018 Dec;8(12):1566-1581. doi: 10.1158/2159-8290.CD-18-0140. Epub 2018 Sep 5.

6.

IEX-1 deficiency induces browning of white adipose tissue and resists diet-induced obesity.

Shahid M, Javed AA, Chandra D, Ramsey HE, Shah D, Khan MF, Zhao L, Wu MX.

Sci Rep. 2016 Apr 11;6:24135. doi: 10.1038/srep24135.

7.

Anti-OX40L alone or in combination with anti-CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen.

Gattringer M, Baranyi U, Pilat N, Hock K, Klaus C, Ramsey HE, Wrba F, Valenta R, Wekerle T.

Clin Exp Allergy. 2016 Feb;46(2):354-64. doi: 10.1111/cea.12661.

8.

A20 modulates lipid metabolism and energy production to promote liver regeneration.

Damrauer SM, Studer P, da Silva CG, Longo CR, Ramsey HE, Csizmadia E, Shrikhande GV, Scali ST, Libermann TA, Bhasin MK, Ferran C.

PLoS One. 2011 Mar 17;6(3):e17715. doi: 10.1371/journal.pone.0017715.

9.

A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression.

Ramsey HE, Da Silva CG, Longo CR, Csizmadia E, Studer P, Patel VI, Damrauer SM, Siracuse JJ, Daniel S, Ferran C.

Liver Transpl. 2009 Nov;15(11):1613-21. doi: 10.1002/lt.21879.

10.

The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells.

Daniel S, Patel VI, Shrikhande GV, Scali ST, Ramsey HE, Csizmadia E, Benhaga N, Fisher MD, Arvelo MB, Ferran C.

Transplant Proc. 2006 Dec;38(10):3225-7.

11.

A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia.

Patel VI, Daniel S, Longo CR, Shrikhande GV, Scali ST, Czismadia E, Groft CM, Shukri T, Motley-Dore C, Ramsey HE, Fisher MD, Grey ST, Arvelo MB, Ferran C.

FASEB J. 2006 Jul;20(9):1418-30.

PMID:
16816117
12.

Phase II study of topotecan in metastatic hormone-refractory prostate cancer.

Hudes GR, Kosierowski R, Greenberg R, Ramsey HE, Fox SC, Ozols RF, McAleer CA, Giantonio BJ.

Invest New Drugs. 1995;13(3):235-40.

PMID:
8729952
13.

Primary melanoma of the cervix: report of a case.

Ramsey HE, Smith HB.

J Natl Med Assoc. 1981 Dec;73(12):1149-51.

14.

Improvements in birefringent filters. 6: Analog birefringent elements.

Title AM, Ramsey HE.

Appl Opt. 1980 Jun 15;19(12):2046-58. doi: 10.1364/AO.19.002046.

PMID:
20221180
15.

Adenocarcinoma arising in Barrett's esophagus with Zollinger-Ellison syndrome.

Symonds DA, Ramsey HE.

Am J Clin Pathol. 1980 Jun;73(6):823-6.

PMID:
7395808
16.
17.

Staging laparotomy in Hodgkin's disease. Further evidence in support of its clinical utility.

O'Connell MJ, Wiernik PH, Sklansky BD, Greene WH, Abt AB, Kirschner RH, Ramsey HE, Murphy WL.

Am J Med. 1974 Jul;57(1):86-91. No abstract available.

PMID:
4834509
18.

Subclinical immune complex nephritis in patients with Hodgkin's disease.

Sutherland JC, Markham RV Jr, Ramsey HE, Mardiney MR Jr.

Cancer Res. 1974 May;34(5):1179-81. No abstract available.

19.

Factors in the control of colon and rectal cancer.

Ramsey HE.

Md State Med J. 1974 Mar;23(3):43-6. No abstract available.

PMID:
4816341
20.

Testicular feminization syndrome in three sibs: emphasis on gonadal neoplasia.

Connell MJ, Ramsey HE, Whang-Peng J, Wiernik PH.

Am J Med Sci. 1973 Apr;265(4):321-33. No abstract available.

PMID:
4735906
21.

Laparotomy and splenectomy in the staging of untreated patients with Hodgkin's disease.

Zarembok I, Ramsey HE, Sutherland J, Serpick AA.

Radiology. 1972 Mar;102(3):673-8. No abstract available.

PMID:
5060180
22.

Splenectomy in Hodgkin's Disease for splenomegaly, cytopenias and intolerance to myelosuppressive chemotherapy.

Lowenbraun S, Ramsey HE, Serpick AA.

Am J Med. 1971 Jan;50(1):49-55. No abstract available.

PMID:
5539576
23.

Embryonal cell carcinoma of the ovary. Report of a case.

Meriwether WD, Ramsey HE, Ward SP.

Oncology. 1971;25(6):497-504. No abstract available.

PMID:
5164224
24.

Progressive fibrous dysplasia of the maxilla.

Ramsey HE, Strong EW, Frazell EL.

J Am Dent Assoc. 1970 Dec;81(6):1388-91. No abstract available.

PMID:
5273605
25.

The results of treatment of lung cancer by surgery, radiation and chemotherapy at a USPHS hospital.

Rockswold GL, Ramsey HE, Buker GD.

Mil Med. 1970 May;135(5):362-8. No abstract available.

PMID:
4991199
26.

Evaluation of common germicidal agents for surgical scrubs.

Ramsey HE, Piecoro J, Brancato F.

J Natl Med Assoc. 1970 May;62(3):232-5. No abstract available.

27.

Endobronchial lipoma. A review of the literature and report of an unusual case.

Ramsey HE, Oster W, Foreman S.

Ann Otol Rhinol Laryngol. 1969 Dec;78(6):1281-90. No abstract available.

PMID:
5369291
28.

The importance of radical lobectomy in lung cancer.

Ramsey HE, Cahan WG, Beattie EJ, Humphrey C.

J Thorac Cardiovasc Surg. 1969 Aug;58(2):225-30. No abstract available.

PMID:
5798227
29.

Post-mastectomy angiosarcoma in the male.

Ramsey HE, Lucas JC Jr, Gray G Jr.

J Natl Med Assoc. 1968 Nov;60(6):468-70. No abstract available.

30.

Fibrous dysplasia of the craniofacial bones.

Ramsey HE, Strong EW, Frazell EL.

Am J Surg. 1968 Oct;116(4):542-7. No abstract available.

PMID:
5676905
31.

Chest wall resection for primary carcinoma of the lung.

Ramsey HE, Cliffton EE.

Ann Surg. 1968 Mar;167(3):342-51. No abstract available.

32.

Bloodless removal of gangrenous pelvic organs at bedside. Report of a case.

Karasewich EG, Ramsey HE, Ego-Aguirre E, Brunschwig A.

Obstet Gynecol. 1966 Dec;28(6):857-60. No abstract available.

PMID:
5923360
33.

Clinical results of non-staining impregnation for caries, prophylaxis and desensitization.

RAMSEY HE, LEWIS CH.

Surg Circ Lett U S Army Far East Command Med Sect. 1949 Jun;4(6):17. No abstract available.

PMID:
18147060

Supplemental Content

Loading ...
Support Center